SAN FRANCISCO – Invitae Corporation (NYSE: NVTA), a genetic information company, today announced it will be presenting seven posters at the 2015 American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting in Salt Lake City.
The titles and schedule of the poster presentations are as follows:
Poster Session 1: Thursday, March 26, 10:30 am – 12:00 pm MT
Poster Session 2: Friday, March 27, 10:30 am – 12:00 pm MT
For more detailed information, please visit http://www.acmgmeeting.net/acmg2015/public/mainhall.aspx
Invitae’s (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Currently focused on hereditary cancers, Invitae’s goal is to aggregate most of the world’s genetic tests into a single service with higher quality, faster turnaround time and lower price than many single-gene tests today. The company currently provides a single diagnostic test comprising over 200 genes for a variety of genetic conditions associated primarily with cancer, but also covering cardiology, hematology, neurology, and pediatrics.
Source: Invitae Corporation